| Title |
Prospective study on the relationship between infections and multiple sclerosis exacerbations |
| Published in |
Brain: a journal of neurology. ISSN 0006-8950. |
| Author |
Buljevac, D.; Flach, H.Z. (Zwenneke); Hop, W.C.J. (Wim); Hijdra, D.; Laman, J.D. (Jon); Savelkoul, H.F.J. (Huub); Meché, van der F.G.A.; Doorn, van P.A. (Pieter); Hintzen, R.Q. (Rogier) |
| Date |
2002-01-01 |
| Language |
English |
| Type |
article |
| Abstract |
One of the characteristics of multiple sclerosis is the unpredictable
occurrence of exacerbations and remissions. These fluctuations in disease
activity are related to alterations in (auto-)immune activity.
Exacerbations lead to short-term morbidity, but may also influence
long-term disability. This longitudinal study in 73 patients with
relapsing-remitting multiple sclerosis assessed the contribution of
systemic infections to the natural course of exacerbations. In addition,
we analysed whether infections lead to an increase in the number of
gadolinium-enhancing lesions. A total of 167 infections and 145
exacerbations were observed during 6466 patient weeks. During a predefined
at-risk period (ARP) of 2 weeks before until 5 weeks after the onset of a
clinical infection (predominantly upper airway infections), there was an
increased risk of exacerbations (rate ratio 2.1), which is in accordance
with previous studies. Exacerbations with onset during the ARP led more
frequently to sustained deficit [increase of > or =1 Expanded Disability
Status Scale (EDSS) point or > or =0.5 above EDSS 5.5 for >3 months] than
exacerbations with onset outside the ARP, with a rate ratio of 3.8. Minor
and major exacerbations were equally distributed between the ARP and
non-ARP onset groups. ARP exacerbations were associated with significantly
higher plasma levels of the inflammatory marker soluble intracellular
adhesion molecule 1 than non-ARP exacerbations, indicating relatively
enhanced immune activation during ARP relapses. Three serial MRI scans
were performed after the onset of an infection over a 6-week period. There
was no difference in the number of gadolinium-enhancing lesions between
the three time points. In conclusion, exacerbations in the context of a
systemic infection lead to more sustained damage than other exacerbations.
There is no indication that this effect occurs through enhanced opening of
the blood-brain barrier. |
| Publication |
http://hdl.handle.net/1765/9887 |
| Persistent Identifier |
urn:NBN:nl:ui:15-1765/9887 |
| Metadata |
XML |
| Repository |
Erasmus University Rotterdam |